Purpose of umbilical cord mesenchymal stem cell exosome

A technology of mesenchymal stem cells and exosomes, applied in the field of stem cell culture, can solve problems such as unsatisfactory hematopoietic stem cell effects and hematopoietic stem cell damage
CN106399247AInactive Publication Date: 2017-02-15GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD
Publication Date
2017-02-15
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of stem cell culture, and particularly relates to a purpose of umbilical cord mesenchymal stem cell exosome. Shown by experiments, with respect to culture experiments adopting a complete medium, by adopting co-culture of the umbilical cord mesenchymal stem cell exosome and peripheral blood stem cells, the amount of cells acquired by culture can be increased by about 1.5 times, and a clone formation amount is also increased by about 1.5 times. Through statistical analysis, compared with a culture effect without the umbilical cord mesenchymal stem cell exosome, the experiment effect with addition of the umbilical cord mesenchymal stem cell exosome has an extremely remarkable difference (p is smaller than 0.001).
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of stem cell culture, in particular to the use of umbilical cord mesenchymal stem cell exosomes. Background technique

[0002] Peripheral hematopoietic stem cells are hematopoietic stem cells present in peripheral blood. In 1979, Goldman et al. collected cryopreserved peripheral blood cells for a group of chronic myeloid leukemia patients in the accelerated phase or blast transition phase at the initial diagnosis, so that the patients returned to the chronic phase, and began the clinical application of peripheral blood hematopoietic stem cell transplantation (PBSCT).

[0003] Under normal circumstances, the content of stem / progenitor cells in peripheral blood accounts for 0.01% to 0.1% of mononuclear cells, which is equivalent to 1% to 10% of bone marrow. After mobilization, CD34 in peripheral blood MNCs + The number of cells and CFU were significantly higher than those of bone marrow. So far, it has been found that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More